CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | CAUSEY CHRISTOPHER Director | Option exercise 10b5-1 | +1,000 | $119.76 | $120K | 5,190 |
| 2026-01-02 | CAUSEY CHRISTOPHER Director | Sale 10b5-1 | −1,000 | $500.01 | $500K | 4,190 |
| 2026-01-02 | CAUSEY CHRISTOPHER Director | Option exercise · Stock Option 10b5-1 | −1,000 | 8,320 | ||
| 2026-01-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise 10b5-1 | +8,300 | $146.03 | $1.2M | 45,081 |
| 2026-01-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −822 | $481.26 | $396K | 44,259 |
| 2026-01-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −479 | $481.83 | $231K | 43,780 |
| 2026-01-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −739 | $483.35 | $357K | 43,041 |
| 2026-01-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,240 | $484.54 | $601K | 41,801 |
| 2026-01-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,509 | $485.68 | $733K | 40,292 |
| 2026-01-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,130 | $486.85 | $550K | 39,162 |
| 2026-01-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,181 | $487.76 | $1.1M | 36,981 |
| 2026-01-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −200 | $489.15 | $98K | 36,781 |
| 2026-01-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise · Stock Option 10b5-1 | −8,300 | 66,700 | ||
| 2025-12-29 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise 10b5-1 | −14,625 | $117.76 | $1.7M | 14,625 |
| 2025-12-29 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −14,625 | $502.79 | $7.4M | 0 |
| 2025-12-29 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise 10b5-1 | +7,875 | $146.03 | $1.1M | 7,875 |
| 2025-12-29 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −7,875 | $502.79 | $4.0M | 0 |
| 2025-12-29 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise · Stock Options 10b5-1 | −14,625 | 111,750 | ||
| 2025-12-29 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise · Stock Options 10b5-1 | −7,875 | 60,190 | ||
| 2025-12-24 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise 10b5-1 | +11,000 | $146.03 | $1.6M | 47,781 |
Page 164 of 171 · 3,408 trades